Dana Pizzuti Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
Dana Pizzuti is Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 66,270 shares of CRNX, which is worth approximately $2.85 Million. The most recent transaction as insider was on Mar 20, 2024, when has been sold 14,375 shares (Common Stock) at a price of $16.89 per share, resulting in proceeds of $242,793. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
66.3K
8.26%
3M change
132.47%
12M change
Total Value Held
$2.85 Million
Dana Pizzuti Transaction History
DP
Dana Pizzuti
Chief Med and Dev Officer
San Diego, CA